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The postsynaptic density protein PSD-95 influences
synaptic AMPA receptor (AMPAR) content and may
play a critical role in LTD. Here we demonstrate that
the effects of PSD-95 on AMPAR-mediated synaptic
responses and LTD can be dissociated. Our findings
suggest that N-terminal-domain-mediated dimeriza-
tion is important for PSD-95’s effect on basal synap-
tic AMPAR function, whereas the C-terminal SH3-GK
domains are also necessary for localizing PSD-95 to
synapses. We identify PSD-95 point mutants (Q15A,
E17R) that maintain PSD-95’s influence on basal
AMPAR synaptic responses yet block LTD. These
point mutants increase the proteolysis of PSD-95
within its N-terminal domain, resulting in a C-terminal
fragment that functions as a dominant negative likely
by scavenging critical signaling proteins required for
LTD. Thus, the C-terminal portion of PSD-95 serves
a dual function. It is required to localize PSD-95 at
synapses and as a scaffold for signaling proteins
that are required for LTD.
INTRODUCTION
Activity-dependent regulation of excitatory synaptic strength
by synaptic incorporation or retrieval of a-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid receptors (AMPARs) are key
mechanisms underlying several prominent forms of synaptic
plasticity (Bredt and Nicoll, 2003; Collingridge et al., 2004; Mal-
enka and Bear, 2004; Malinow and Malenka, 2002; Sheng and
Kim, 2002; Shepherd and Huganir, 2007). Thus, elucidating the
detailed molecular processes that control AMPAR content at
synapses is critical for understanding the neural substrates of
various forms of developmental and experience-dependent
plasticity, including learning and memory. Substantial evidence
suggests that the postsynaptic density protein of 95 kDa (PSD-
95; also known as synapse associated protein 90, SAP90) is
one key component of the postsynaptic molecular architecture
that controls synaptic AMPAR content and thereby synaptic248 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.strength. Most importantly, acute overexpression of PSD-95
causes a large enhancement of AMPAR- but not NMDAR-medi-
ated EPSCs in hippocampal neurons (AMPAR EPSCs and
NMDAR EPSCs, respectively), while acute knockdown of
PSD-95 via RNA interference (RNAi) decreases AMPAR EPSCs
but, in most studies, not NMDAR EPSCs (Beique and Andrade,
2003; Beique et al., 2006; Ehrlich and Malinow, 2004; Ehrlich
et al., 2007; Elias et al., 2006; Futai et al., 2007; Nakagawa
et al., 2004; Schluter et al., 2006; Schnell et al., 2002).
Molecular manipulations of PSD-95 also appear to profoundly
influence synaptic plasticity. Hippocampal slices prepared
from mutant mice lacking PSD-95 expressed greatly enhanced
NMDAR-dependent long-term potentiation (LTP), whereas
NMDAR-dependent long-term depression (LTD) was absent
(Migaud et al., 1998). Conversely, overexpression of PSD-95 oc-
cluded LTP (Ehrlich and Malinow, 2004; Stein et al., 2003) and
decreased the threshold for LTD induction (Beique and Andrade,
2003; Stein et al., 2003). These results suggest that PSD-95 may
be indispensable for NMDAR-dependent LTD of AMPAR EPSCs.
However, there are several limitations to the interpretation of
these results. First, manipulation of PSD-95 may influence pre-
synaptic function (Futai et al., 2007; Migaud et al., 1998), and
this in turn may influence the ability of specific induction proto-
cols to elicit LTP or LTD. Second, since the molecular manipula-
tions of PSD-95 profoundly affect basal synaptic strength, it is
difficult to know whether the observed effects on LTP and LTD
are secondary to this change in synaptic strength or rather
because in addition to influencing AMPAR synaptic content,
PSD-95 plays an independent critical role in the triggering or
expression of LTD.
Two general possibilities exist for a role of PSD-95 in LTD.
Based on the strong effects of manipulating PSD-95 levels on
basal synaptic transmission, it has been proposed that PSD-95
may act as a ‘‘slot’’ protein for synaptic AMPARs (Colledge
et al., 2003; Ehrlich and Malinow, 2004; Schnell et al., 2002). In
this role, PSD-95 would be a target of the signaling cascade trig-
gered by LTD induction, and a reduction of synaptic PSD-95
levels would lead to the long-term loss of synaptic AMPARs.
Consistent with this hypothesis, two biochemical modifications
of PSD-95, polyubiquitination (Colledge et al., 2003) and depal-
mitoylation (El-Husseini Ael et al., 2002), have been reported to
be required for the removal of synaptic PSD-95 and hence the
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cited by agonist application. Although the agonist-induced en-
docytosis of AMPARs in cultured neurons has served as a valu-
able model for synaptically induced LTD in slices (Carroll et al.,
1999, 2001; Sheng and Kim, 2002), the mechanisms underlying
endocytosis of AMPARs in culture and LTD in slices may not be
identical. In addition, the direct polyubiquitination of PSD-95 in
response to NMDAR activation has been questioned (Patrick
et al., 2003), and molecular manipulations that perturb polyubi-
quitination or palmitoylation of PSD-95 may mislocate PSD-95.
Thus, the disruption of agonist-induced AMPAR endocytosis
caused by interfering with these biochemical modifications of
PSD-95 may not be due to the disruption of its native functional
properties.
Alternatively, PSD-95 may be important for LTD as a molecular
scaffold that connects NMDAR-mediated calcium entry to the
downstream enzymatic machinery that triggers LTD. Similar to
other members of the family of synaptic membrane-associated
guanylate kinase proteins (MAGUKs) PSD-95 contains multiple
protein-protein interaction motifs, including three consecutive
N-terminal PDZ (PSD-95, discs large, zona occludens 1) domains
and C-terminal Src homology 3 (SH3) and guanylate kinase-like
(GK) domains (Kim and Sheng, 2004; Montgomery et al., 2004).
While the PDZ domains appear important for binding PSD-95 di-
rectly to NMDARs or indirectly to AMPARs via TARPs (Chen et al.,
2000; Kornau et al., 1995; Niethammer et al., 1996; Schnell et al.,
2002), the SH3 and GK domains interact with several proteins that
may influence intracellular signaling cascades. Specifically, the
SH3-GK domains of PSD-95 interact with A-kinase-anchoring
protein 79/150 (AKAP79/150), guanylate kinase-associated pro-
tein (GKAP), and spine-associated RapGAP (SPAR) (Kim and
Sheng, 2004; Montgomery et al., 2004). The binding of PSD-95
to AKAP79/150 is of particular interest because AKAP79/150 in
turn binds to protein kinase A and the Ca2+/calmodulin-depen-
dent protein phosphatase calcineurin (PP2B), both of which ap-
pear to be important for LTD (Kameyama et al., 1998; Mulkey
et al., 1994). Indeed, dynamic interactions between AKAP79/
150, PSD-95 family proteins, and PP2B may regulate synaptic
AMPAR levels in cultured neurons (Tavalin et al., 2002).
Here, we use a lentivirus-mediated molecular replacement
strategy (Schluter et al., 2006), which allows simultaneous RNA
interference-mediated knockdown of endogenous PSD-95 and
expression of mutant forms of recombinant PSD-95 in single
cells, to study the molecular determinants of PSD-95 for regulat-
ing basal AMPAR-mediated synaptic strength and mediating
LTD. We find that PSD-95 regulates basal synaptic AMPAR con-
tent in a manner that requires both its N-terminal domain, which
mediates homomeric dimerization/multimerization necessary for
synaptic enrichment of PSD-95, as well as its C-terminal do-
mains, which are required for its localization at synapses. We
then demonstrate that the role of PSD-95 in controlling basal
AMPAR-mediated synaptic strength can be dissociated from
its role in LTD. Analysis of a series of deletion constructs and
point mutants support the hypothesis that PSD-95, via its C-ter-
minal protein-protein interaction domains, functions as a critical
signaling scaffold to couple the NMDAR-mediated rise in cal-
cium to the intracellular signaling cascades that are required
for the triggering of LTD.RESULTS
Regulation of Basal Synaptic Strength by PSD-95
Requires Both N- and C-Terminal Domains
Previous studies have shown that acute changes in PSD-95 level
affect the size of AMPAR-mediated synaptic responses (Beique
and Andrade, 2003; Ehrlich and Malinow, 2004; Ehrlich et al.,
2007; Elias et al., 2006; Futai et al., 2007; Nakagawa et al.,
2004; Schluter et al., 2006; Schnell et al., 2002). Overexpression
of deletion constructs specifically suggested that the N-terminal
portion of PSD-95 containing the PDZ1 and PDZ2 domains is
localized to synapses (Craven et al., 1999) and alone is sufficient
to mediate the increase of AMPAR EPSCs (Schnell et al., 2002).
However, a similar deletion mutant is still present in the original
PSD-95 knockout mice but was reported to be absent from the
PSD (Migaud et al., 1998). This discrepancy raised the possibility
that the presence of endogenous PSD-95 might play a role in
mediating the effect of this deletion mutant on AMPAR EPSCs
when overexpressed. To address this issue, we compared the
effects of the N-terminal segment of PSD-95 including the first
two PDZ domains (PSD-95PDZ1 + 2, fused to GFP) on basal syn-
aptic transmission when overexpressed versus when expressed
in the absence of detectable levels of endogenous PSD-95,
which was reduced by simultaneous expression of a short-hair-
pin RNA (shRNA) directed against PSD-95 (sh95) (Schluter et al.,
2006). Consistent with previous studies (Schnell et al., 2002),
PSD-95PDZ1 + 2 overexpression selectively increased AMPAR
EPSCs but not NMDAR EPSCs when compared to simulta-
neously recorded, uninfected neighboring cells (Figure 1A). Con-
sistent with its effects on synaptic transmission, PSD-95PDZ1 + 2
had a highly punctate expression pattern in dendrites when GFP
fluorescence was examined by confocal microscopy (Figure 1A,
right panel). Surprisingly, however, when PSD-95PDZ1 + 2 was
expressed while simultaneously reducing the level of endoge-
nous PSD-95, using an approach we have termed ‘‘molecular
replacement’’ (Schluter et al., 2006), AMPAR EPSCs in infected
cells were reduced to a degree essentially identical to that ob-
served with expression of sh95 alone (Figures 1B and 1E). This
was in contrast to the dramatic effects of replacing endogenous
PSD-95 with wild-type PSD-95 (Figure 1E) (Schluter et al., 2006).
Furthermore, consistent with its lack of effect on basal synaptic
transmission, the expression pattern of PSD-95PDZ1 + 2, when
expressed in the absence of detectable endogenous PSD-95, is
diffuse, not punctuate, in dendrites (Figure 1B, right panel).
A deletion mutant lacking the SH3 and GK domains (PSD-
95DSH3-GK) behaved similarly to PSD-95PDZ1 + 2. Whereas
overexpression of PSD-95DSH3-GK increased AMPAR EPSCs,
expression of PSD-95DSH3-GK with greatly reduced endoge-
nous PSD-95 did not rescue the decrease of AMPAR EPSCs
caused by sh95 (Figures 1C and 1D). The dramatic differences
between the synaptic effects of these two PSD-95 deletion con-
structs when overexpressed in the presence or virtual absence
of endogenous PSD-95 are summarized in Figures 1E and 1F.
Importantly, whereas overexpression of wild-type PSD-95 in-
creased AMPAR EPSCs to an identical extent under both condi-
tions, replacement of endogenous PSD-95 with C-terminal
domain deletion mutants could not rescue the decrease of
AMPAR EPSCs caused by the large reduction of endogenousNeuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc. 249
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Are Required for Its Effects on Basal
AMPAR EPSCs
(A) Amplitude (mean ± SEM) of AMPAR EPSCs
(left panel, uninfected 34.9 ± 3.5 pA, infected,
59.6 ± 5.7 pA, p < 0.001) and NMDAR EPSCs
(middle panel, uninfected 50.7 ± 5.7 pA, infected,
59.1 ± 5.9 pA, p > 0.05) of neurons expressing
PSD-95PDZ1 + 2::GFP are plotted against those
of simultaneously recorded uninfected neighbor-
ing neurons. (In this and all subsequent panels:
gray symbols represent single pairs of recordings;
black symbols show mean ± SEM; p values were
calculated with a paired Student’s t test compar-
ing absolute values of paired recordings.) Inserts
in each panel show sample averaged traces
(gray traces, infected neurons; black traces,
uninfected neighboring neurons; scale bars, 50
pA/20 ms for AMPAR EPSCs; 50 pA/50 ms for
NMDAR EPSCs). Right panels show confocal
images of GFP fluorescence (scale bars, 20 mm,
left panel, and 2 mm, right panel).
(B) Amplitudes (mean ± SEM) of AMPAR EPSCs
(uninfected 60.1 ± 5.5 pA, infected 30.6 ± 3.8
pA, p < 0.001) and NMDAR EPSCs (uninfected
64.7 ± 9.7 pA, infected 49.6 ± 7.4 pA, p < 0.01) of
neurons expressing sh95 + PSD-95PDZ1 + 2::GFP
and uninfected neighboring neurons. Right panels
show confocal images of GFP fluorescence (scale
bars, 20 mm, left panel, and 2 mm, right panel).
(C) Amplitudes (mean ± SEM) of AMPAR EPSCs
(uninfected42.6 ± 4.5 pA, infected69.1 ± 5.5 pA,
p < 0.001) and NMDAR EPSCs (uninfected 36.0 ±
5.6 pA, infected 34.8 ± 3.4 pA, p > 0.05) of neurons
expressing PSD-95DSH3-GK::GFP and unin-
fected neighboring neurons.
(D) Amplitudes (mean ± SEM) of AMPAR EPSCs
(uninfected 62.0 ± 5.5 pA, infected 30.3 ±
3.0 pA, p < 0.001) and NMDAR EPSCs (uninfected
87.8 ± 10.5 pA, infected 72.0 ± 9.1 pA, p < 0.01) of
neurons expressing sh95 + PSD-95DSH3-GK-
IRES-GFP and uninfected neighboring neurons.
(E) Summary (mean ± SEM) of effects of express-
ing various forms of PSD-95 alone or with sh95 on
AMPAR EPSCs calculated as the averaged ratios
obtained from pairs of infected and uninfected
neighboring neurons (2.17 ± 0.37, 2.25 ± 0.35,
2.35 ± 0.31, 2.52 ± 0.23, 0.51 ± 0.10, 0.56 ± 0.07,
0.59 ± 0.03, respectively, numbers of pairs analyzed are indicated in the bar; n.s. indicates p > 0.05; ***p < 0.001 using an ANOVA Tukey HSD t test).
(F) Summary (mean ± SEM) of effects of same manipulations as in (E) on NMDAR EPSCs (1.21 ± 0.11, 1.36 ± 0.12, 1.23 ± 0.18, 1.20 ± 0.15, 0.80 ± 0.04,
0.85 ± 0.06, 0.88 ± 0.04, respectively, n.s. indicates p > 0.05).PSD-95. These data suggest that the C-terminal region of PSD-
95 containing the SH3-GK domains is important for the localiza-
tion of PSD-95 at the PSD and hence for the effect of PSD-95 on
AMPAR EPSCs. In addition, these results suggest that in the
absence of adequate levels of endogenous PSD-95, N-terminal
portions of PSD-95 either cannot target to synapses appropri-
ately or are not maintained in the PSD at a location that allows
them to influence synaptic AMPAR levels.
N-Terminal Domain of PSD-95 Is Required
for Dimerization
Because of the requirement of the full-length PSD-95 for the
effects of PSD-95 C-terminal domain deletion mutants on basal250 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.synaptic AMPAR function, we hypothesized that homotypic inter-
actions of the mutants with endogenous PSD-95 are likely critical
for targeting and stabilizing their localization at synapses. The
importance of PSD-95 N-terminal domain homotypic interac-
tions have been studied previously, but the results are confusing,
with some papers reporting an important role for these interac-
tions in mediating the dimerization of PSD-95 while others sug-
gest that the important function of the N-terminal domain is solely
because of its palmitoylation (Figure 2A) (Christopherson et al.,
2003; Hsueh et al., 1997; Hsueh and Sheng, 1999; Nakagawa
et al., 2004; Topinka and Bredt, 1998). To examine the role of
the PSD-95 N-terminal domain in dimerization, we coexpressed
untagged PSD-95 with GFP-tagged PSD-95 or GFP-tagged
Neuron
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lysates using GFP antibody and immunoblotted with PSD-95
antibody. Consistent with the electrophysiological results, both
the full-length PSD-95 and PSD-95PDZ1 + 2 mutant can coim-
munoprecipitate the untagged PSD-95 (Figure 2B). In fact, the
N-terminal 64 amino acids of PSD-95 fused to GFP were suffi-
cient to coimmunoprecipitate full-length PSD-95 (Figure 2B) as
well as a peptide containing only the N-terminal 32 amino acids
(data not shown), indicating an N-terminal domain homotypic
interaction.
To further test the importance of the N-terminal domain of PSD-
95 for its dimerization, we examined two previously described
PSD-95 mutants, PSD-95DPEST, which lacks a motif that has
been suggested to be important for PSD-95 polyubiquitination
(Colledge et al., 2003), and PSD-95C3,5S, which cannot be
palmitoylated (El-Husseini Ael et al., 2002). Neither one of these
N-terminal domain mutant constructs was capable of coimmu-
noprecipitating the full-length PSD-95, further supporting a role
for an N-terminal domain homotypic interaction (Figure 2B).
Previous studies have reported that overexpression of PSD-
95C3,5S has no effect on AMPAR EPSCs, likely because it is
not maintained at synapses (Schnell et al., 2002). To determine
whether PSD-95DPEST, in terms of its functional effects, be-
haved like PSD-95C3,5S or wild-type PSD-95, we measured
AMPAR EPSCs in cells in which it had been overexpressed
and found that it had no detectable effect (Figure 2C). Further-
more, confocal microscopy revealed that PSD-95DPEST did
not exhibit the highly punctuate expression pattern in dendrites
that is a hallmark of wild-type PSD-95 (Figure 2D). These results
are consistent with the suggestion that the synaptic effects of
PSD-95 require its dimerization or multimerization via its N-ter-
Figure 2. N-Terminal-Mediated Interactions
Are Required for PSD-95 to Affect Basal
AMPAR EPSCs
(A) Conserved motif in the N terminus of vertebrate
PSD-95.
(B) PSD-95 can dimerize through its N terminus.
Western blot of input (top panel) and proteins im-
munoprecipitated using GFP antibody (bottom
panel) from HEK cells transfected with the indi-
cated constructs and blotted with PSD-95 anti-
body.
(C) Overexpression of PSD-95DPEST::GFP does
not affect the amplitude (mean ± SEM) of basal
AMPAR EPSCs (uninfected 52.0 ± 6.5 pA, in-
fected 58.4 ± 7.6 pA, p > 0.05, n = 42 pairs) nor
NMDAR EPSCs (uninfected 67.5 ± 7.3 pA, infected
62.7 ± 6.9 pA, p > 0.05, n = 20 pairs) (scale bars,
50 pA/20 ms for AMPAR EPSCs; 50 pA/50 ms
for NMDAR EPSCs).
(D) Confocal images of GFP from neurons infected
with PSD-95DPEST::GFP and PSD-95::GFP (scale
bars, 20 mm, top panels, and 2 mm, bottom panels).
minal domain. Specifically, overexpres-
sion of mutant forms of PSD-95 that were
able to dimerize/multimerize with full-
length PSD-95 clearly enhanced basal
AMPAR EPSCs, whereas N-terminal
domain mutations that prevented dimerization did not affect
basal synaptic responses. Together with the previous results,
these data also suggest that both the N- and C-terminal domains
of PSD-95 are important for mediating its effects on AMPAR
EPSCs. While PSD-95 can dimerize or multimerize through its
N-terminal domain and the PDZ domains are important for inter-
acting with AMPARs and NMDARs, we suggest that at least one
C-terminal SH3-GK domain is important for localizing a given set
of interacting PSD-95 proteins within the PSD, potentially by an-
choring it within the postsynaptic protein network.
Acute Knockdown of PSD-95 Impairs LTD
Previous studies using knockout mice lacking synaptic PSD-95
reported the absence of LTD (Migaud et al., 1998). However,
PSD-95 was absent throughout development in these experi-
ments, and changes in short-term synaptic plasticity were ob-
served, both of which might have affected the generation of
LTD. Here, we examined LTD after acute knockdown of PSD-
95 using lentivirus-mediated shRNA, a manipulation that had
no detectable effects on presynaptic function (Elias et al., 2006;
Schluter et al., 2006) and which minimizes the possibility of
developmental compensations. When compared to the LTD in
simultaneously recorded control cells, acute knockdown of
PSD-95 greatly reduced the magnitude of LTD (Figures 3A and
3B; control 50% ± 10% of baseline, sh95 80% ± 8%, n = 15).
One simple explanation for this reduction in LTD magnitude
caused by sh95 is that it is due to the reduction in basal synaptic
strength combined with some sort of floor effect below which
AMPAR EPSCs cannot be further reduced. Alternatively, PSD-
95 might play a critical role in mediating LTD independent of its
effects on basal synaptic strength. In this case, the incompleteNeuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc. 251
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Rescued by Replacement with Wild-Type or Prenylated PSD-95
(A) Sample experiment showing simultaneous recording of LTD of AMPAR
EPSCs from an uninfected control cell (A1) and an sh95-infected neighboring
cell (A2). Downward arrow in this and all subsequent figures indicates time at
which LTD induction protocol was given. In this and all subsequent figures,
traces above the graph show averaged EPSCs (20–40 consecutive responses)
taken at the times indicated by the numbers on the graph (thick traces, aver-
aged EPSCs from baseline; thin traces, averaged EPSCs after LTD induction;
scale bars, 20 pA/20 ms).
(B1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95-infected cells (n = 15 pairs). In this and all subsequent summary graphs,
points represent mean ± SEM.
(B2)SummarygraphofLTD ofAMPAR EPSCsfrom pairsofuninfectedandsh95-
infected cells, normalized to the baseline responses of each cell. (n = 15 pairs).
(C) Sample experiment illustrating LTD of AMPAR EPSCs from an uninfected
control cell (C1) and an sh95 + PSD-95::GFP infected neighboring cell (C2)
recorded simultaneously.
(D1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95::GFP infected cells (n = 18 pairs).
(D2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95::GFP infected cells, normalized to the baseline responses of
each cell (n = 18 pairs).252 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.block of LTD can be attributed to some functional redundancy
with other MAGUK family members (Elias et al., 2006).
To distinguish these possibilities, a dissociation of the role of
PSD-95 in regulating basal synaptic transmission and LTD is re-
quired. To determine whether this could be achieved, we exam-
ined the synaptic effects of replacing endogenous PSD-95 with
a number of different PSD-95 mutant constructs, focusing on
mutations in the N-terminal domain. Before testing mutants,
however, it was important to confirm that replacement of endog-
enous PSD-95 with recombinant wild-type PSD-95 could rescue
the deficit in LTD. As expected, coexpression of sh95 with wild-
type PSD-95 enhanced basal synaptic strength (Schluter et al.,
2006) and restored LTD to normal (Figures 3C and 3D).
Previous studies have suggested that N-terminal domain mod-
ifications of PSD-95, specifically its polyubiquitination (Colledge
et al., 2003) and depalmitoylation (El-Husseini Ael et al., 2002),
are important for agonist-induced endocytosis of AMPARs in cul-
tured neurons. It was therefore of interest to examine the effects
of the mutant forms of PSD-95 used in these studies on synapti-
cally evoked LTD. However, PSD-95DPEST, the mutant that was
reported to block polyubiquitination, was not targeted to synap-
ses normally and did not have an effect on basal AMPAR EPSCs
(Figures 2C and 2D). Therefore, we did not examine its effects on
LTD. We did examine PSD-95 fused to GFP containing a prenyla-
tion signal peptide. This lipid modification has been shown to
confer constitutive membrane binding to PSD-95 and thus pre-
vent its membrane detachment (El-Husseini Ael et al., 2002).
Importantly, it was found to impair agonist-induced endocytosis
of AMPARs (El-Husseini Ael et al., 2002). Using the molecular re-
placement approach, this construct rescued basal AMPAR-me-
diated synaptic transmission similar to wild-type PSD-95::GFP
(Figure 3E1). However, it also rescued LTD (Figures 3E1 and
3E2), suggesting that detachment of PSD-95 from the plasma
membrane is not required for synaptically evoked LTD.
N-Terminal Domain Point Mutants Dissociate
the Effects of PSD-95 on Basal Transmission and LTD
Although examining N-terminal domain mutant forms of PSD-95
that had been reported to affect AMPAR endocytosis in culture
did not prove useful in dissecting the role of PSD-95 in LTD, we
next pursued the possibility that polyubiquitination of PSD-95
was required for this form of synaptic plasticity. Based on the
highly conserved PEST motif (Figure2A),we reasoned that chang-
ing the negatively charged glutamate at residue 17 to a positively
charged arginine (E17R mutation) might disrupt the PEST function
that was suggested to be required for PSD-95 polyubiquitination
(Colledge et al., 2003; Rechsteiner and Rogers, 1996). As a
control construct, we generated a more conservative glutamine
to alanine mutation at residue 15 (Q15A mutation). Using the mo-
lecular replacement strategy to examine the effects of these point
mutants on basal AMPAR EPSCs revealed that they rescued the
decrease in synaptic strength caused by sh95 to the same degree
(E1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95::GFPprenyl infected cells (n = 10 pairs).
(E2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95::GFPprenyl infected cells, normalized to the baseline responses
of each cell (n = 10 pairs).
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Regulation of Synaptic Strength and LTD by PSD-95Figure 4. Replacement of Endogenous PSD-95 with E17R or Q15A
Point Mutants Rescues Basal AMPAR EPSCs yet Blocks LTD
(A) Amplitude (mean ± SEM) of AMPAR EPSCs of neurons expressing sh95 +
PSD-95E17R::GFP (left panel, uninfected 21.7 ± 3.0 pA; infected 62.5 ±
7.7 pA; p < 0.001) and sh95 + PSD-95Q15A::GFP (middle panel, uninfected
40.4 ± 3.8 pA; infected135.1 ± 14.0 pA; p < 0.001) are plotted against those
of simultaneously recorded uninfected neighboring neurons. Right panel shows
summary of effects on AMPAR EPSCs of expressing sh95 + PSD-95::GFP,
sh95 + PSD-95E17R::GFP, and sh95 + PSD-95Q15A::GFP (2.72 ± 0.25, 3.77 ±
0.66, 3.76 ± 0.45, n.s. indicates p > 0.05).
(B) Sample experiment illustrating LTD of AMPAR EPSCs from an uninfected
control cell (B1) and an sh95 + PSD-95E17R::GFP infected neighboring cell
(B2) recorded simultaneously.
(C1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95E17R::GFP infected cells (n = 15 pairs; in this and subsequent
summary graphs, points represent mean ± SEM).
(C2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95E17R::GFP infected cells, normalized to the baseline re-
sponses of each cell (n = 15 pairs).
(D) Sample experiment illustrating LTD of AMPAR EPSCs from an uninfected
control cell (D1) and an sh95 + PSD-95Q15A::GFP infected neighboring cell
(D2) recorded simultaneously.
(E1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95Q15A::GFP infected cells (n = 12 pairs).as wild-type PSD-95 (Figure 4A). These results demonstrate that
these PSD-95 point mutants traffic to synapses normally and are
able to fulfill the normal function of PSD-95 in regulating basal
synaptic strength. Surprisingly, however, LTD was blocked in
cells expressing either point mutant (Figures 4B–4E), a result
demonstrating that the effects of PSD-95 on basal AMPAR
EPSCs and LTD are dissociable and therefore must involve dis-
tinct protein-protein interactions.
Truncation of PSD-95 Blocks LTD
Because these point mutants were generated to test the role of
PSD-95 polyubiquitination in LTD, we examined whether they
affected this biochemical modification of PSD-95 by expressing
them in HEK293 cells with HA-tagged ubiquitin. Both point
mutants showed ubiquitination patterns essentially identical to
that of wild-type PSD-95 (data not shown). However, both point
mutants (Figure 5A) exhibited an increased amount of PSD-95
with an increased electrophoretic mobility when compared to
wild-type PSD-95 (Figure 5B). To determine whether the gener-
ation of the smaller form of PSD-95 is an intrinsic property of
PSD-95 processing in neurons, we infected dissociated cortical
cultures with molecular replacement viruses that expressed ei-
ther wild-type PSD-95 or one of the two point mutants, all tagged
at the C terminus with GFP. Similar to the results in HEK293 cells,
the N-terminal domain point mutations increased the production
of the smaller PSD-95 (Figure 5C). This additional PSD-95 band
appears to be an N-terminal domain truncated form of PSD-95,
as it has a smaller molecular weight and can be immunoprecip-
itated by a GFP antibody but is not recognized by an antibody
directed against the N-terminal domain of PSD-95 (Schluter
et al., 2006). Moreover, the truncated product of PSD-95 was
present in a crude synaptosomal P2 fraction prepared from the
infected neuron cultures (Figure 5D), and an increase in its pro-
duction was also observed when slice cultures were infected
with replacement viruses expressing the E17R mutant versus
wild-type PSD-95 (Figure 5E). An additional, lower molecular
weight truncation product was also apparent when wild-type
PSD-95 or the point mutants were expressed in HEK293 cells
(Figure 5F1). This band has been observed previously (Colledge
et al., 2003; Morabito et al., 2004; Sans et al., 2000), and its rel-
ative amount was not affected by the E17R and Q15A point
mutants that blocked LTD.
Because the N-terminal region of PSD-95 is important for me-
diating homomeric interactions that are critical for PSD-95 to ex-
ert its effects on synaptic function, we tested whether these two
point mutants influence PSD-95 dimerization by coexpressing
the mutant forms of GFP-tagged PSD-95 with untagged PSD-
95 and performing coimmunoprecipitation experiments. Similar
to wild-type PSD-95, both of the point mutants coimmunopreci-
pitated full-length PSD-95 (Figure 5F). However, the untagged
truncation products, which were readily detected in the cell
lysate (Figure 5F1), could not be detected in the GFP antibody
precipitated material (Figure 5F2). These results provide further
evidence that the truncation of PSD-95 caused by the E17R
(E2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95Q15A::GFP infected cells, normalized to the baseline re-
sponses of each cell (n = 12 pairs).Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc. 253
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in the N Terminus of PSD-95 Increase Its
Truncation
(A) Positions of the two point mutations are shown.
(B) In HEK293 cells, E17R and Q15A mutants show
increased amounts of truncated PSD-95 com-
pared to wild-type PSD-95.
(C) The increased truncation of E17R and Q15A
mutants is present in neurons infected with the
indicated replacement viruses.
(D) The truncated form of PSD-95 is present in
a crude, synaptosomal P2 fraction prepared from
cortical neuron cultures infected with the indicated
replacement constructs.
(E) The increased truncation of the E17R mutant is
present in hippocampal slice cultures infected
with the indicated replacement viruses.
(F) The E17R and Q15A mutants dimerize, but the
truncated PSD-95 does not. Western blot of input
(F1) and proteins immunoprecipitated with GFP-
antibody (F2) from HEK cells transfected with the
indicated constructs.
Q15A mutation no longer occurred
(Figures 7D and 7E). Together with the
findings from the overexpression experi-
ments, these results suggest that the
blockade of LTD by the PSD-95 N-termi-
nal domain point mutants is due to their
increased truncation.and Q15A point mutations results in the loss of its N-terminal
region, which is critical for normal dimerization/multimerization.
Since the point mutants had the same effect on basal synaptic
strength as wild-type PSD-95 and our previous results indicated
that N-terminal-domain-mediated dimerization is important for
this synaptic function of PSD-95, we hypothesized that the block-
ade of LTD by expression of these mutants was due to a domi-
nant-negative effect of the truncated fragment of PSD-95. As
an initial test of this prediction, we overexpressed PSD-95E17R
or PSD95Q15A with the expectation that truncation of these re-
combinant proteins will still occur and inhibit LTD. Indeed, ex-
pression of these PSD-95 mutants significantly increased basal
AMPAR EPSCs while simultaneously blocking LTD (Figure 6).
To more narrowly define the site in PSD-95 at which its trunca-
tion occurs, we made two deletions in the N-terminal region,
amino acid residues 33–53 and 45–64. While deletion of residues
33–53 did not prevent the truncation of PSD-95 (data not shown),
deletion of residues 45–64 in the PSD-95Q15A mutant (PSD-
95Q15AD45-64) completely blocked its truncation (Figures 7A
and 7B), suggesting that the proteolysis occurred in the region
of PSD-95 between residues 53 and 64. Consistent with this con-
clusion, coimmunoprecipitation experiments in HEK293 cells re-
vealed that this construct still interacted normally with full-length
PSD-95 (Figure 7C). Most importantly, replacement of endoge-
nous PSD-95 with PSD-95Q15AD45-64 rescued basal AMPAR
EPSCs to a level comparable to wild-type PSD-95, but LTD
was normal, indicating that the block of LTD caused by the254 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.Increased Truncation of PSD-95 Q15A and E17R
Mutants Increases Their Mobility in Spines
We have provided evidence that both the C- and N-terminal do-
mains of PSD-95 are important for its synaptic targeting and
stabilization at synapses and that N-terminal-domain-mediated
dimerization/multimerizaton is important for its effects on basal
AMPAR EPSCs. If our conclusion that the Q15A and E17R point
mutants increase the proteolysis of PSD-95 at synapses and
thereby the generation of C-terminal fragments is correct, we
would expect these point mutants to be less stable at synapses
than wild-type PSD-95. To test this prediction, we examined the
basal mobility of PSD-95 at synapses using time-lapse imaging
of wild-type and mutant forms of PSD-95 fused to photoactivat-
able GFP (PAGFP) at their C termini (Gray et al., 2006; Patterson
and Lippincott-Schwartz, 2002). Expression of wild-type
PSD-95 using the molecular replacement strategy revealed that
it was relatively stable within individual dendritic spines with
75% of the original spine fluorescence being retained 60 min
after photoactivation (Figures 8A and 8E). (dsRed was also ex-
pressed so that spines on the transfected cells were easily iden-
tifiable.) The retained pool of PSD-95 presumably reflects protein
that is anchored within the spine and therefore limited in its ability
to diffuse away from the site of photoactivation. After 60 min of
imaging, a second photoactivation pulse (PA0) returned spine
PAGFP fluorescence to its original value (Figures 8A and 8E).
This suggests that the total amount of wild-type PSD-95 within
the spine remains relatively constant, likely due to an exchange
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pool.
The Q15A and E17R PSD-95 point mutants within spines were
dramatically less stable in that only 40% of the original spine
fluorescence was present at 60 min after photoactivation (Fig-
ures 8B, 8C, and 8F). This is likely due to the generation of C-ter-
minal fragments fused to the GFP that are no longer able to
dimerize and thus are free to diffuse out of the PSD and spine.
To test this hypothesis, we examined the deletion mutant that
prevents the proteolysis of Q15A PSD-95 (PSD-95Q15AD45-
64) and found that it behaved identically to wild-type PSD-95
(Figures 8D and 8G). The increased rate of movement of the pho-
toactivated Q15A and E17R mutants out of the spines does not
reflect a net loss of spine PSD-95 but rather an increase in the
exchange of PSD-95 within spines as a second photoactivation
pulse returned PAGFP fluorescence to its original values. To-
gether with previous results, these imaging experiments show
that there is a direct correlation between the increase in trunca-
tion of PSD-95, the increased rate of dissociation of PSD-95 from
the stable spine pool, and the blockade of LTD.
LTD Is Blocked by the C-Terminal Fragment of PSD-95
The results thus far suggest that the fragments generated by the
truncation of PSD-95 play a dominant-negative role in blocking
LTD. Because the C-terminal fragment contains protein-protein
interaction motifs including the SH3 and GK domains, which inter-
act with proteins that are part of downstream signaling com-
plexes such as AKAP, we predicted that the C-terminal fragment
of the truncated PSD-95 functioned as a dominant-negative in-
hibitor of LTD. An apparently straightforward manipulation to
Figure 6. Overexpression of E17R or Q15A Mutants Blocks LTD
(A1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95E17R::GFP infected cells (n = 17 pairs; in this and subsequent sum-
mary graphs, points represent mean ± SEM).
(A2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95E17R::GFP infected cells, normalized to the baseline responses of
each cell (n = 17 pairs).
(B1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95Q15A::GFP infected cells (n = 13 pairs).
(B2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95Q15A::GFP infected cells, normalized to the baseline responses of
each cell (n = 13 pairs).test this hypothesis is to overexpress the C-terminal fragment
of PSD-95 alone and determine whether it impairs LTD. However,
the fact that mutations in its N-terminal domain prevented PSD-
95 from being targeted to synapses normally and having any ef-
fect on basal AMPAR EPSCs led us to predict that a form of
PSD-95 lacking its N-terminal domain also would not be targeted
to synapses normally. Consistent with this prediction, PSD-95
lacking its N-terminal 53 amino acids (PSD-95D2-53) did not dis-
play a highly punctuate expression pattern when examined with
confocal microscopy (data not shown). Overexpression of
PSD-95D2-53 also did not affect basal AMPAR EPSCs (n = 12
pairs; uninfected cells 38.8 ± 7.1 pA; infected cells 39.7 ±
5.6 pA) nor did it impair LTD (n = 6, 59% ± 8% of baseline).
Because PSD-95 lacking its N-terminal domain was not tar-
geted to synapses normally and did not affect LTD, we could
not use it to probe which specific portions of the C-terminal do-
main were required for blocking LTD. Instead, we made muta-
tions in the C-terminal domain of PSD-95Q15A, which we had
already established blocked LTD, presumably because after be-
ing targeted to synapses normally it was proteolyzed to produce
a dominant-negative C-terminal fragment. To determine whether
the SH3-GK domains in the truncated C-terminal portion of PSD-
95 were required for the blockade of LTD, we deleted them from
the PSD-95Q15A mutant (PSD-95Q15ADSH3-GK) as well as from
wild-type PSD-95 (PSD-95DSH3-GK). If the N-terminal fragment
of truncated PSD-95 was responsible for inhibiting LTD, LTD
should still be blocked by PSD-95Q15ADSH3-GK. However, if
the C-terminal fragment containing SH3-GK domains is the criti-
cal LTD inhibitor, LTD will be unaffected. As expected from pre-
vious results, overexpression of the wild-type deletion construct
(PSD-95DSH3-GK) increased basal AMPAR EPSCs and had no
effect on LTD, presumably because the SH3-GK domains of en-
dogenous PSD-95 could still subserve their normal functions
(Figure 9A). Expression of PSD-95Q15ADSH3-GK had the same
effects (Figure 9B); it increased basal synaptic transmission and
in contrast to overexpression of PSD-95Q15A (Figure 6), it did
not impair LTD. This result indicates that the C-terminal portion
of the truncated full-length PSD-95 must contain the SH3-GK
domains to inhibit LTD.
To further narrow down the site in the C-terminal domain of
PSD-95 that is crucial for mediating LTD, we tested an additional
point mutant in the SH3 domain, L460P. In the Drosophila homo-
log Dlg, this point mutation exhibits a severe phenotype (Woods
et al., 1996), and biochemical studies suggest that it disrupts
the interaction of the PSD-95 SH3 domain with AKAP79/150
but not the interaction of PSD-95 with GKAP (Colledge et al.,
2000; McGee and Bredt, 1999). Replacement of endogenous
PSD-95 with PSD-95L460P still clearly enhanced basal AMPAR
EPSCs while LTD was dramatically reduced (Figure 9C). How-
ever, when this point mutation was added to the Q15A point mu-
tant and overexpressed (PSD-95Q15AL460P), it behaved like
PSD-95Q15DSH3-GK, not like PSD-95Q15A; it enhanced basal
AMPAR EPSCs and had no effect on LTD (Figure 9D). These re-
sults provide further evidence that the C-terminal portion of the
truncated full-length PSD-95 inhibits LTD and suggest that this
occurs because of the disruption of PSD-95’s interactions with
downstream signaling proteins that are required for LTD, such
as AKAP79/150.Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc. 255
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The general acceptance that activity-dependent trafficking of
AMPARs into and away from synapses is important for many
forms of synaptic and experience-dependent plasticity (Bredt
and Nicoll, 2003; Collingridge et al., 2004; Malenka and Bear,
2004; Malinow and Malenka, 2002; Sheng and Kim, 2002;
Shepherd and Huganir, 2007) has generated great interest in elu-
cidating the detailed molecular mechanisms by which AMPAR
content at synapses is controlled. PSD-95, a member of the
MAGUK family of synapse-associated proteins, has received
great attention in this context as a putative synaptic scaffold pro-
tein, which functions to ‘‘tether’’ AMPARs at the appropriate site
within the PSD (Bredt and Nicoll, 2003; Kim and Sheng, 2004;
Montgomery et al., 2004; Shepherd and Huganir, 2007). Based
on a variety of approaches, including overexpression of wild-
type and mutant forms of PSD-95, shRNA-mediated knock-
down of PSD-95, and genetic deletion of PSD-95, a model has
evolved, suggesting that PSD-95 (as well as certain other sub-
family members) indirectly binds to AMPARs via interactions be-
tween its first two PDZ domains and one of the AMPAR accessory
proteins termed TARPs (Chen et al., 2000; Nicoll et al., 2006;
Schnell et al., 2002). PSD-95 has also been suggested to play
an important role in NMDAR-dependent forms of LTP and LTD
(Ehrlich et al., 2007; Migaud et al., 1998), although the detailed
molecular mechanisms underlying this putative function have
not been defined. Indeed, it has remained unclear whether any in-
fluence that PSD-95 has on LTP or LTD is entirely due to its effects
on regulating AMPAR content at synapses and/or some addi-
tional role as a scaffold for downstream signaling complexes.
Figure 7. Deletion of Amino Acid Residues
45–64 Prevents the Increased Truncation
of the PSD-95Q15A Mutant and Rescues
LTD
(A) Amino acid sequence of the N-terminal domain
of PSD-95Q15AD45-64, showing the position of
the deletion.
(B) Western blot showing that in HEK293 cells
PSD-95Q15AD45-64 is not truncated.
(C) PSD-95Q15AD45-64 dimerizes. Western blot
of input (upper panel) and proteins immunoprecip-
itated with GFP antibody (lower panel) from
HEK cells transfected with the indicated con-
structs.
(D) Summary graph of LTD of AMPAR EPSCs from
pairs of uninfected and sh95 + PSD-95 Q15AD45-
64::GFP infected cells (n = 11 pairs; in this and
subseqent summary graphs, points represent
mean ± SEM).
(E) Summary graph of LTD of AMPAR EPSCs from
pairs of uninfected and sh95 + PSD-95 Q15AD45-
64::GFP infected cells, normalized to the baseline
responses of each cell (n = 11 pairs).
Furthermore, many of the elegant bio-
chemical and cell-biological properties
of PSD-95 that have been reported have
not been examined for their relevance to
synaptic function.
Here, we have used a molecular replacement strategy com-
bined with a standard overexpression approach to further de-
fine the molecular properties of PSD-95 that are responsible
for its roles in regulating basal AMPAR-mediated synaptic
transmission and LTD. We present evidence that N-terminal-
domain-mediated homomeric interactions, presumably dimer-
ization or multimerization, are critical for the regulation of basal
AMPAR-mediated synaptic transmission. Surprisingly, in con-
trast to previous reports, we also demonstrate that the PSD-
95 C-terminal domain, in particular the SH3-GK domain, is
also required for this function of PSD-95, likely because it is cru-
cial for localizing PSD-95 to synapses. Most importantly, we
demonstrate that the role of PSD-95 in regulating synaptic AM-
PAR function and LTD can be molecularly dissociated. Single
amino acid point mutations in its N-terminal domain allow
PSD-95 to affect basal synaptic strength in a manner identical
to wild-type PSD-95 yet block LTD (Figure 10A). We present ev-
idence that the blockade of LTD is due to the production of a C-
terminal fragment of PSD-95 caused by increased proteolysis in
the N-terminal region of the PSD-95 point mutants. We suggest
that the PSD-95 C-terminal fragment plays a dominant role in
blocking LTD by interfering with the binding of critical down-
stream signaling complexes (Figures 10A and 10B). Together
our results are consistent with the general idea that PSD-95 is
an important multifunctional protein within the PSD. Indepen-
dent of its role in tethering AMPARs at the PSD, it is required
for LTD likely because of critical C-terminal SH3-GK domain
protein interactions. Our results specifically implicate PSD-95
and AKAP79/150 interactions as being particularly important
for LTD.256 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.
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It is generally accepted that AMPARs interact with PSD-95 via
TARPs and that these interactions are important for the synaptic
localization and function of AMPARs (Chen et al., 2000; Nicoll
et al., 2006; Schnell et al., 2002). Based on overexpression stud-
ies, it was determined that the minimum requirements for PSD-95
to influence synaptic AMPAR function were its N-terminal palmi-
toylation, which appears to be required for its synaptic targeting
(El-Husseini Ael et al., 2002), and its first two PDZ domains, which
are required to interact with TARPS (Schnell et al., 2002). How-
ever, using an approach that allows replacement of endogenous
PSD-95 with mutant forms of PSD-95, we found that forms of
PSD-95 lacking its C-terminal domain (PSD-95PDZ1 + 2 as well
as PSD-95DSH3-GK) were unable to influence basal AMPAR
EPSCs. Importantly, when overexpressed, these constructs
clearly enhanced basal synaptic strength in a manner similar to
that of wild-type PSD-95. These results demonstrate that the
full length of PSD-95 is required for it to influence synaptic AM-
PARs, likely because the C-terminal SH3-GK domain is critical
Figure 8. The E17R and Q15A Point Mutants
Show IncreasedDiffusionOut of Spines Due
to Their Truncation
(A–D) Sample images of spines from neurons
expressing dsRed and the indicated forms of
PSD-95 fused to photoactivatable GFP. At time 0’,
GFP was photoactivated, and changes in fluores-
cence intensity were monitored at the indicated
times. A second photoactivation was performed
after 60 min of imaging (PA0).
(E) Summary graph of loss of GFP fluorescence
from individual spines from cells expressing sh95
and wild-type PSD-95 (n = 17/5 spines/cells; in
this and subseqent summary graphs, points repre-
sent mean ± SEM).
(F) Summary graphs of loss of GFP fluorescence
from individual spines from cells expressing
sh95 with PSD-95E17R (n = 25/5 spines/cells) or
PSD-95Q15A (n = 23/5 spines/cells). Open circles
indicate time points at which the values are statis-
tically different (p < 0.05) compared to the corre-
sponding time point in wild-type cells. For com-
parison, the summary graph of wild-type PSD-95
(mean ± SEM) is shown in the gray shaded region.
(G) Summary graph of loss of GFP fluorescence
from individual spines from cells expressing sh95
with PSD-9Q15A5D45-64 (n = 27/5 spines/cells).
For comparison, the summary graphs of wild-type
PSD-95 (gray) and Q15A PSD-95 (pink) are also
shown.
for localizing or stabilizing PSD-95 at the
synapse. When overexpressed, the trun-
cated forms of PSD-95 containing the first
two or three PDZ domains were able to
have clear synaptic effects presumably
because of their interactions with endog-
enous, synaptically localized, full-length
PSD-95. The synaptic stabilization of
PSD-95 may be mediated by its C-termi-
nal domain interaction with GKAP and/or SPAR, which link
PSD-95 to the postsynaptic protein network (Kim and Sheng,
2004). These results also explain the apparent discrepancy be-
tween the previous overexpression study showing that PSD-
95PDZ1 + 2 had a clear effect on increasing synaptic AMPAR
EPSCs (Schnell et al., 2002) and that from the PSD-95 mutant
mice where the similar protein product was not present in the
PSD (Migaud et al., 1998).
We also found that previously studied PSD-95 mutants con-
taining mutations in the N-terminal domain but an intact C-termi-
nal domain, specifically the PSD-95C3,5S and PSD-95DPEST
mutants, cannot interact with wild-type PSD-95 and as a conse-
quence do not localize to synapses nor increase AMPAR EPSCs.
These results suggest that an N-terminal-domain-mediated in-
teraction, perhaps combined with or mediated by palmitoylation,
is required for the enrichment of PSD-95 at synapses and for the
effect of PSD-95 on basal AMPAR EPSCs. Previous biochemical
studies on whether PSD-95 exists as a monomer or rather as a
dimer/multimer due to N-terminal domain interactions areNeuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc. 257
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the assays and expression systems used (Christopherson
et al., 2003; Hsueh et al., 1997; Hsueh and Sheng, 1999; Naka-
gawa et al., 2004; Topinka and Bredt, 1998). Based on a func-
tional readout of the effects of N-terminal domain mutations
Figure 9. The Block of LTD by Q15A PSD-95 Requires C-Terminal
Domain Interactions
(A1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95DSH3-GK::GFP infected cells (n = 12 pairs; in this and subsequent
summary graphs, points represent mean ± SEM).
(A2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95DSH3-GK::GFP infected cells, normalized to the baseline responses
of each cell (n = 12 pairs).
(B1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95Q15ADSH3-GK::GFP infected cells (n = 11 pairs).
(B2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
PSD-95Q15ADSH3-GK::GFP infected cells, normalized to the baseline re-
sponses of each cell (n = 11 pairs).
(C1) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95L460P::GFP infected cells (n = 10 pairs).
(C2) Summary graph of LTD of AMPAR EPSCs from pairs of uninfected and
sh95 + PSD-95L460P::GFP infected cells, normalized to the baseline re-
sponses of each cell (n = 10 pairs).
(D1) Summary graph of LTD of AMPAR EPSCs from uninfected (n = 8) and
PSD-95Q15AL460P::GFP infected cells (n = 11). Data include five pairs of
simultaneously recorded uninfected and infected cells, and additional cells
recorded individually from slice cultures injected with lentiviruses expressing
PSD-95Q15AL460P::GFP.
(D2) Summary graph of LTD of AMPAR EPSCs from uninfected (n = 8) and
PSD-95Q15AL460P::GFP infected cells (n = 11), normalized to the baseline
responses of each cell.258 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.(i.e., the effects of PSD-95 on basal AMPAR EPSCs) combined
with coimmunoprecipitation assays, our results are consistent
with the idea that PSD-95 dimerizes (or multimerizes) via N-ter-
minal domain interactions and that this is critical for its effects
on synaptic function. In agreement with previous work (Christo-
pherson et al., 2003), our experiments indicate that the two cys-
teines at positions 3 and 5 in the N-terminal region are critical for
the interaction, as is the PEST motif (residues 10–25). Further
biochemical studies will be needed to determine the role of pal-
mitoylation of the two cysteines in mediating dimerization, with
one possibility being that palmitoylation of the N terminus ex-
poses a motif that allows dimerization to occur (Christopherson
et al., 2003).
The Role of PSD-95 in LTD
Results from overexpression and acute knockdown studies
suggest that basal AMPAR-mediated synaptic strength directly
correlates with synaptic PSD-95 level under normal conditions.
In contrast, the same molecular manipulations of PSD-95 either
have no effects on NMDAR-mediated synaptic responses or
effects that are dramatically less than those on AMPAR-mediated
responses (Ehrlich et al., 2007; Elias et al., 2006; Futai et al., 2007;
Nakagawa et al., 2004; Schluter et al., 2006). In the present work,
shRNA-mediated knockdown of PSD-95 had no detectable
effect on NMDAR EPSCs (n = 145, Figure 1F). However, in the ex-
periments involving the replacement of endogenous PSD-95 with
mutant forms of PSD-95 lacking C-terminal domains (Figure 1),
on average small decreases (15%–20%) in NMDAR EPSCs
were observed. This raises the formal possibility that changes
in NMDAR-mediated synaptic responses may have influenced
the ability to trigger LTD when endogenous PSD-95 was replaced
with point mutants that impaired or blocked LTD. This possibility,
however, can be ruled out by the observation that the effects of
replacing endogenous PSD-95 with recombinant PSD-95 on
NMDAR EPSCs (Figure 1F, n = 13) were the same as those ob-
served when replacing endogenous PSD-95 with the E17R/
Q15A point mutants that blocked LTD (n = 16, p > 0.05).
The strong correlation between PSD-95 levels and AMPAR
EPSCs raises the possibility that during LTP and LTD the level
of synaptic PSD-95 might change in accordance with the change
in synaptic AMPAR content. Ubiquitination (Colledge et al., 2003)
and depalmitoylation (El-Husseini Ael et al., 2002) of PSD-95
have been suggested as two possible biochemical modifications
that may regulate synaptic PSD-95 level during synaptic plastic-
ity. Specifically, the removal of PSD-95 from synapses by ubiq-
uitination and depalmitoylation were reported to be required for
agonist-induced endocytosis of AMPARs in cultured neurons
(Colledge et al., 2003; El-Husseini Ael et al., 2002). Surprisingly,
we found that the key mutant used to study the role of PSD-95
polyubiquitination in AMPAR endocytosis, PSD-95DPEST (Col-
ledge et al., 2003), did not traffic normally to synapses and did
not affect basal AMPAR EPSCs. We also examined PSD-95
fused to a GFP with a C-terminal prenylation motif, which pre-
vented the loss of PSD-95 from the membrane due to depalmi-
toylation and blocked glutamate-induced AMPAR endocytosis
in culture (El-Husseini Ael et al., 2002). While this construct did
enhance basal synaptic responses, it had no effect on LTD.
One explanation for these apparent discrepancies in results is
Neuron
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in culture primarily examined the trafficking of nonsynaptic
AMPARs. Alternatively, the role of PSD-95 in agonist-induced
AMPAR endocytosis in cultured neurons may be different than
its role in LTD. In either case, our results suggest that membrane
dissociation of PSD-95 is not required for LTD, at least during its
first 40 or so minutes.
Our results instead suggest a role for PSD-95 in LTD indepen-
dent of its function in tethering AMPARs at the synapse. Based
on the finding that generation of a C-terminal fragment of PSD-
95 requiring its SH3-GK domains blocked LTD yet did not pre-
vent PSD-95 from influencing basal synaptic strength, we pro-
pose that interactions between the SH3-GK domains and key
downstream signaling molecules are critical for the generation
of LTD. The effects of the L460P point mutant suggest that
a prime candidate for one such key protein is AKAP79/150, an
adaptor protein that interacts with PP2B and PKA, two enzymes
implicated in LTD (Kameyama et al., 1998; Mulkey et al., 1994).
Via its binding to these enzymes, AKAP79/150 has been sug-
Figure 10. Summary of the Effect of PSD-95
Manipulations on Basal Transmission and
LTD
(A) Summary of the effects of PSD-95 manipula-
tions on LTD. Percentage of the baseline response
at 35–40 min after LTD induction is plotted (mean
± SEM). Open bars, infected cells; gray bars, unin-
fected cells.
(B) Left panel: model for the role of PSD-95 in basal
synaptic AMPAR function. Left side of spine
shows the normal condition with endogenous
PSD-95 present. Right side shows the conse-
quences of overexpressing PSD-95PDZ1 + 2,
which can interact with endogenous PSD-95 and
recruit additional AMPARs. Replacing endoge-
nous PSD-95 with PSD-95PDZ1 + 2 or expressing
PSD-95C3,5S or PSD-95DPEST leaves these pro-
teins outside the spine because they cannot di-
merize with endogenous PSD-95. (Whether PSD-
95DPEST is palmitoylated is not known.) Right
panel: model for the role of PSD-95 as a signaling
scaffold for LTD. Left side of spine shows the nor-
mal condition in which PSD-95 interacts with a
complex of signaling proteins that is activated by
NMDAR-mediated influx of calcium (red arrow)
during LTD induction. Right side shows truncated
PSD-95 interacting with the signaling complex
away from the NMDAR such that it cannot be
activated by calcium.
gested to be important for the regulation
of AMPAR phosphorylation and hence
channel function in dissociated neuron
cultures (Colledge et al., 2000; Oliveria
et al., 2003; Rosenmund et al., 1994;
Tavalin et al., 2002). It also has been
reported to translocate from synapses to
cytoplasm upon stimulation of NMDARs
in neuron cultures in a manner that may
contribute to LTD induction and expres-
sion (Smith et al., 2006). More consistent
with the view of AKAP function in mediating LTD signaling
events, rather than in regulating basal AMPAR function, is our
finding that the PSD-95 L460P point mutant, which presumably
interfered with its binding to AKAP and prevented LTD, still had
normal effects on basal AMPAR synaptic responses. Further
electrophysiological studies of PSD-95 C-terminal mutants that
inhibit specific protein-protein interactions will be required to de-
termine whether PSD-95/AKAP interactions alone or interactions
of PSD-95 with other signaling proteins are also required for LTD.
Conclusion
Using a molecular replacement approach, we have examined
the role of specific N-terminal and C-terminal molecular motifs
in PSD-95 in mediating its role in the regulation of basal synaptic
AMPAR function and LTD. We have provided evidence that
these two functions of PSD-95 can be clearly dissociated, yet
that full-length PSD-95 is required for both. Our results are
consistent with the idea that at the synapse PSD-95 exists
as a dimer/multimer due to N-terminal domain interactions.Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc. 259
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izing PSD-95 at the synapse as well as for coupling it to down-
stream signaling complexes. PSD-95 dimerization or multimeri-
zation at synapses is likely required because individual PSD-95
molecules cannot simultaneously interact with the large number
of requisite interacting proteins that are required for it to sub-
serve its multiple functions (Figure 10B). Thus, consistent with
previous conceptualizations of the role of PSD-95 (Kim and
Sheng, 2004; Migaud et al., 1998), based upon our functional
analysis of PSD-95 mutants we conclude that PSD-95 serves
as both a structural scaffold involved in tethering AMPARs at
the synapse and as a signaling scaffold that is required for LTD.
EXPERIMENTAL PROCEDURES
DNA Constructs and Virus Production
See Supplemental Data for details about generation of DNA constructs and
lentiviruses.
Dissociated Neuronal Cultures
Dissociated neuronal cultures were prepared from newborn Sprague-Dawley
pups as previously described (Schluter et al., 2006). Briefly, papain-digested
hemispheres of cortex were triturated and plated on poly-D-lysine-coated
10 cm culture dishes in B-27 supplemented Neurobasal media and then re-fed
subsequently with N-2 supplemented MEM plus GlutaMax (Invitrogen). Glial
growth was inhibited by FUDR at 3 DIV.
Antibodies and Western Blots
The following antibodies were used: mouse monoclonal PSD95 antibody (Affin-
ity Bioreagents), rabbit polyclonal GFP antibody (Molecular Probe), goat anti-
mouse conjugated with Alexa 680 (Invitrogen), goat anti-rabbit conjugated
with Alexa 680 (Invitrogen), goat anti-mouse conjugated with IRDye800 (Rock-
land), goat anti-rabbit conjugated with IRDye800 (Rockland). Neuronal cultures
were collected in ice-cold RIPA buffer (1% Triton X-100, 0.1% SDS, 0.5%
deoxycholic acid, 50 mM NaH2PO4, 150 mM NaCl, 2 mM EDTA, and protease
inhibitor cocktail [Roche], pH7.4) and diluted with SDS-PAGE sample buffer
(BioRad). Hippocampi were collected and homogenized in ice-cold homogeni-
zation buffer. A crude synaptosomal fraction P2 was solubilized in SDS-PAGE
sample buffer after protein concentrations were adjusted. Samples were
separated on 4%–12% gradient Bis-Tris gels (Invitrogen), transferred on nitro-
cellulose and decorated with the indicated antibodies. Signals of fluorescent-
dye-labeled secondary antibodies were detected and quantified with an Odys-
sey Infrared Imaging System (Li-Cor Biotechnology).
HEK293 cells were transfected at 60%–80% confluency in 10 cm plates
using Fugene 6 (Roche). Cells were harvested and lysed 24–48 hr after trans-
fection in 500 ml RIPA buffer, extracted at 4C for 1 hr, and spun for 20 min at
>30,000 g. Cell extracts were subjected to immunoprecipitation using 1–3 mg
anti-GFP antibody for 1 hr followed by incubation with 30 ml protein A agarose
(Roche). The immunoprecipitates were washed three times with washing
buffer (10 mM Tris/HCl, pH 7.4, 1 mM EDTA, 250 mM NaCl, and 0.5% TX-100)
followed by a single wash with TBS buffer prior to solubilizing the bound pro-
teins in 30 ml SDS sample buffer. Samples were then run on SDS-PAGE gels for
standard western blotting with indicated antibodies.
Hippocampal Slice Cultures
Procedures for preparation of hippocampal slice cultures were essentially as
described (Schluter et al., 2006). Briefly, hippocampi of 7- to 8-day-old rats
were isolated, and 220 mm slices were prepared using a Vibratome (Leica
Microsystems) in ice-cold sucrose-substituted artificial cerebrospinal fluid
(ACSF; see Electrophysiology section). Slices were transferred onto MilliCell
Culture Plate Inserts (MilliPore) and cultured in Neurobasal-A medium supple-
mented with 1 mg/ml insulin, 0.5 mM ascorbic acid, and 20% horse serum.
Media was changed every second day.260 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.Electrophysiology
A single slice was removed from the insert and placed in the recording cham-
ber where it was constantly perfused with ACSF containing (in mM): 119 NaCl,
26 NaHCO3, 10 glucose, 2.5 KCl, 1 NaH2PO4, 4 MgSO4, 4 CaCl2, and contin-
ually bubbled with 95% O2 and 5% CO2. Picrotoxin (50 mM) was included to
isolate EPSCs, and chloroadenosine (1–2 mM) was added to reduce polysyn-
aptic activity. A single, double-barreled glass pipette filled with ACSF was
used as a bipolar stimulation electrode and was placed within 300 mm of the
recording pipettes in stratum radiatum. The pipette solution for whole-cell volt-
age-clamp recordings contained (in mM): 117.5 CsMeSO3, 10 HEPES, 10
TEACl, 8 NaCl, 15.5 CsCl, 1 MgCl2, 0.25 EGTA, 4 MgATP, 0.3 NaGTP, and 5
QX-314. Data were collected using an Axopatch 700A amplifier or two Axo-
patch 1D amplifiers (Axon Instruments) and digitized at 5 kHz with the A/D con-
verter BNC2090 (National Instruments). Data were acquired and analyzed
on-line using custom routines written with Igor Pro software (Wavemetrics).
AMPAR EPSCs were recorded at –60 mV and measured using a 2 ms window
around the peak. NMDAR EPSCs were recorded at +40 mV and measured
60–65 ms after the initiation of the EPSC. Small, hyperpolarizing voltage steps
were given before each afferent stimulus, allowing on-line monitoring of input
and series resistances. Stimulation pulses were provided at 0.1 or 0.2 Hz. Si-
multaneous, dual whole-cell recordings were established from an infected and
closely adjacent uninfected cell (as indicated by GFP expression and lack
thereof). AMPAR EPSCs were collected after adjusting stimulation strength
so that AMPAR EPSCs in control cells were 10–50 pA, and 40–70 traces
were averaged to obtain the basal AMPAR EPSCs from the two cells. Cells
were then depolarized to +40 mV, allowed to stabilize, and another 25–50
dual-component EPSCs were collected to obtain a measurement of NMDAR
EPSCs. Comparisons between infected and uninfected cell responses were
done using paired t tests. Statistical analyses among different constructs
and conditions were done using one-way analysis of variation (ANOVA) and
Tuckey’s HSD t test. For LTD experiments, at least 6 min of stable baseline re-
sponses (holding potential of60 mV) were collected before the LTD induction
protocol, which consisted of stimulation at 2 Hz for 900 stimulation pulses
while holding cells at 45 mV. In Figures 1E and 1F, the bar graphs showing
the effects of sh95 with or without wild-type PSD-95 were previously published
in Figure 2H in Schluter et al. (2006) as the experiments examining the effects
of PSD-95PDZ1 + 2 and PSD-95DSH3-GK were performed during the same
time period.
Slice Culture Imaging
Slices were fixed with 4% paraformaldehyde, 4% sucrose in PBS buffer for
3 hr at 4C, and were mounted with Fluoromount medium (EMS). Images of
GFP fluorescence of infected neurons in slices were collected with a Zeiss
LSM-510 confocal microscope using a 633, 1.4 NA objective.
Single Spine Imaging
Hippocampal slices cultures were prepared from postnatal day 7 Sprague-
Dawley rats. Slices were biolistically transfected with a Helios Gene Gun (Bio-
rad) at 4 days in vitro (DIV 4). Bullets were prepared using 12.5 mg of 1.6 mm
gold particles and 80 mg of plasmid DNAs for double transfection (40 mg of
each). Slices were maintained onto MilliCell Culture Plate Inserts (Millipore) until
imaging at 9 DIV. All experiments were performed at room temperature in arti-
ficial cerebrospinal fluid (ACSF, in mM): 127 NaCl, 25 NaHCO3, 1.25 NaH2PO4,
2.5 KCl, 1 MgCl2, 25 D-glucose, 2.5 CaCl2), gassed with 95% O2 and 5% CO2.
Transfected CA1 pyramidal neurons were identified at low magnification
(LUMPlanFl 103 0.30 NA objective, Olympus) based on their red fluorescence
and characteristic morphology. Spines of primary or second-order branches of
apical dendrites were imaged and photoactivated at high magnification
(LUMFL 603 1.10 NA objective, Olympus) using a custom-made combined
two-photon laser scanning (2PLS) and two-photon laser photoactivating
(2PLP) microscope as previously described (Bloodgood and Sabatini, 2005;
see Supplemental Data for additional details.).
Supplemental Data
The Supplemental Data for this article can be found online at http://www.
neuron.org/cgi/content/full/57/2/248/DC1/.
Neuron
Regulation of Synaptic Strength and LTD by PSD-95ACKNOWLEDGMENTS
We thank S. Lee, D. Jhung, S. Wu, A. Ghosh, and X. Cai for excellent technical
assistance; C. Garner and J. Tsui for helpful discussions; and C. Garner, W.J.
Nelson, B.Glick, G. Patterson, and C. Lois for constructs and use of equip-
ment. This work was supported by NIH grants MH063394 (to R.C.M.) and
MH075220, MH080310 (to W.X.), DFG grants SCHL592-1 and SCHL592-4
(to O.M.S.) and grants from the Dana and McKnight Foundations (B.S.).
Received: August 20, 2007
Revised: November 1, 2007
Accepted: November 27, 2007
Published: January 23, 2008
REFERENCES
Beique, J.C., and Andrade, R. (2003). PSD-95 regulates synaptic transmission
and plasticity in rat cerebral cortex. J. Physiol. 546, 859–867.
Beique, J.C., Lin, D.T., Kang, M.G., Aizawa, H., Takamiya, K., and Huganir,
R.L. (2006). Synapse-specific regulation of AMPA receptor function by PSD-
95. Proc. Natl. Acad. Sci. USA 103, 19535–19540.
Bloodgood, B.L., and Sabatini, B.L. (2005). Neuronal activity regulates
diffusion across the neck of dendritic spines. Science 310, 866–869.
Bredt, D.S., and Nicoll, R.A. (2003). AMPA receptor trafficking at excitatory
synapses. Neuron 40, 361–379.
Carroll, R.C., Lissin, D.V., von Zastrow, M., Nicoll, R.A., and Malenka, R.C.
(1999). Rapid redistribution of glutamate receptors contributes to long-term
depression in hippocampal cultures. Nat. Neurosci. 2, 454–460.
Carroll, R.C., Beattie, E.C., Von Zastrow, M., and Malenka, R.C. (2001). Role
of AMPA receptor endocytosis in synaptic plasticity. Nat. Rev. Neurosci. 2,
315–324.
Chen, L., Chetkovich, D.M., Petralia, R.S., Sweeney, N.T., Kawasaki, Y., Went-
hold, R.J., Bredt, D.S., and Nicoll, R.A. (2000). Stargazin regulates synaptic tar-
geting of AMPA receptors by two distinct mechanisms. Nature 408, 936–943.
Christopherson, K.S., Sweeney, N.T., Craven, S.E., Kang, R., El-Husseini Ael,
D., and Bredt, D.S. (2003). Lipid- and protein-mediated multimerization of
PSD-95: implications for receptor clustering and assembly of synaptic protein
networks. J. Cell Sci. 116, 3213–3219.
Colledge, M., Dean, R.A., Scott, G.K., Langeberg, L.K., Huganir, R.L., and
Scott, J.D. (2000). Targeting of PKA to glutamate receptors through a
MAGUK-AKAP complex. Neuron 27, 107–119.
Colledge, M., Snyder, E.M., Crozier, R.A., Soderling, J.A., Jin, Y., Langeberg,
L.K., Lu, H., Bear, M.F., and Scott, J.D. (2003). Ubiquitination regulates PSD-
95 degradation and AMPA receptor surface expression. Neuron 40, 595–607.
Collingridge, G.L., Isaac, J.T., and Wang, Y.T. (2004). Receptor trafficking and
synaptic plasticity. Nat. Rev. Neurosci. 5, 952–962.
Craven, S.E., El-Husseini, A.E., and Bredt, D.S. (1999). Synaptic targeting of
the postsynaptic density protein PSD-95 mediated by lipid and protein motifs.
Neuron 22, 497–509.
Ehrlich, I., and Malinow, R. (2004). Postsynaptic density 95 controls AMPA
receptor incorporation during long-term potentiation and experience-driven
synaptic plasticity. J. Neurosci. 24, 916–927.
Ehrlich, I., Klein, M., Rumpel, S., and Malinow, R. (2007). PSD-95 is required
for activity-driven synapse stabilization. Proc. Natl. Acad. Sci. USA 104,
4176–4181.
El-Husseini Ael, D., Schnell, E., Dakoji, S., Sweeney, N., Zhou, Q., Prange, O.,
Gauthier-Campbell, C., Aguilera-Moreno, A., Nicoll, R.A., and Bredt, D.S.
(2002). Synaptic strength regulated by palmitate cycling on PSD-95. Cell
108, 849–863.
Elias, G.M., Funke, L., Stein, V., Grant, S.G., Bredt, D.S., and Nicoll, R.A.
(2006). Synapse-specific and developmentally regulated targeting of AMPA
receptors by a family of MAGUK scaffolding proteins. Neuron 52, 307–320.Futai, K., Kim, M.J., Hashikawa, T., Scheiffele, P., Sheng, M., and Hayashi, Y.
(2007). Retrograde modulation of presynaptic release probability through
signaling mediated by PSD-95-neuroligin. Nat. Neurosci. 10, 186–195.
Gray, N.W., Weimer, R.M., Bureau, I., and Svoboda, K. (2006). Rapid redistri-
bution of synaptic PSD-95 in the neocortex in vivo. PLoS Biol. 4, e370.
Hsueh, Y.P., and Sheng, M. (1999). Requirement of N-terminal cysteines of
PSD-95 for PSD-95 multimerization and ternary complex formation, but not
for binding to potassium channel Kv1.4. J. Biol. Chem. 274, 532–536.
Hsueh, Y.P., Kim, E., and Sheng, M. (1997). Disulfide-linked head-to-head
multimerization in the mechanism of ion channel clustering by PSD-95. Neuron
18, 803–814.
Kameyama, K., Lee, H.K., Bear, M.F., and Huganir, R.L. (1998). Involvement of
a postsynaptic protein kinase A substrate in the expression of homosynaptic
long-term depression. Neuron 21, 1163–1175.
Kim, E., and Sheng, M. (2004). PDZ domain proteins of synapses. Nat. Rev.
Neurosci. 5, 771–781.
Kornau, H.C., Schenker, L.T., Kennedy, M.B., and Seeburg, P.H. (1995).
Domain interaction between NMDA receptor subunits and the postsynaptic
density protein PSD-95. Science 269, 1737–1740.
Malenka, R.C., and Bear, M.F. (2004). LTP and LTD: an embarrassment of
riches. Neuron 44, 5–21.
Malinow, R., and Malenka, R.C. (2002). AMPA receptor trafficking and synap-
tic plasticity. Annu. Rev. Neurosci. 25, 103–126.
McGee, A.W., and Bredt, D.S. (1999). Identification of an intramolecular inter-
action between the SH3 and guanylate kinase domains of PSD-95. J. Biol.
Chem. 274, 17431–17436.
Migaud, M., Charlesworth, P., Dempster, M., Webster, L.C., Watabe, A.M.,
Makhinson, M., He, Y., Ramsay, M.F., Morris, R.G., Morrison, J.H., et al.
(1998). Enhanced long-term potentiation and impaired learning in mice with
mutant postsynaptic density-95 protein. Nature 396, 433–439.
Montgomery, J.M., Zamorano, P.L., and Garner, C.C. (2004). MAGUKs in
synapse assembly and function: an emerging view. Cell. Mol. Life Sci. 61,
911–929.
Morabito, M.A., Sheng, M., and Tsai, L.H. (2004). Cyclin-dependent kinase 5
phosphorylates the N-terminal domain of the postsynaptic density protein
PSD-95 in neurons. J. Neurosci. 24, 865–876.
Mulkey, R.M., Endo, S., Shenolikar, S., and Malenka, R.C. (1994). Involvement
of a calcineurin/inhibitor-1 phosphatase cascade in hippocampal long-term
depression. Nature 369, 486–488.
Nakagawa, T., Futai, K., Lashuel, H.A., Lo, I., Okamoto, K., Walz, T., Hayashi,
Y., and Sheng, M. (2004). Quaternary structure, protein dynamics, and
synaptic function of SAP97 controlled by L27 domain interactions. Neuron
44, 453–467.
Nicoll, R.A., Tomita, S., and Bredt, D.S. (2006). Auxiliary subunits assist AMPA-
type glutamate receptors. Science 311, 1253–1256.
Niethammer, M., Kim, E., and Sheng, M. (1996). Interaction between the C ter-
minus of NMDA receptor subunits and multiple members of the PSD-95 family
of membrane-associated guanylate kinases. J. Neurosci. 16, 2157–2163.
Oliveria, S.F., Gomez, L.L., and Dell’Acqua, M.L. (2003). Imaging kinase–
AKAP79–phosphatase scaffold complexes at the plasma membrane in living
cells using FRET microscopy. J. Cell Biol. 160, 101–112.
Patrick, G.N., Bingol, B., Weld, H.A., and Schuman, E.M. (2003). Ubiquitin-
mediated proteasome activity is required for agonist-induced endocytosis of
GluRs. Curr. Biol. 13, 2073–2081.
Patterson, G.H., and Lippincott-Schwartz, J. (2002). A photoactivatable GFP
for selective photolabeling of proteins and cells. Science 297, 1873–1877.
Rechsteiner, M., and Rogers, S.W. (1996). PEST sequences and regulation by
proteolysis. Trends Biochem. Sci. 21, 267–271.
Rosenmund, C., Carr, D.W., Bergeson, S.E., Nilaver, G., Scott, J.D., and West-
brook, G.L. (1994). Anchoring of protein kinase A is required for modulation of
AMPA/kainate receptors on hippocampal neurons. Nature 368, 853–856.Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc. 261
Neuron
Regulation of Synaptic Strength and LTD by PSD-95Sans, N., Petralia, R.S., Wang, Y.X., Blahos, J., 2nd, Hell, J.W., and Wenthold,
R.J. (2000). A developmental change in NMDA receptor-associated proteins at
hippocampal synapses. J. Neurosci. 20, 1260–1271.
Schluter, O.M., Xu, W., and Malenka, R.C. (2006). Alternative N-terminal
domains of PSD-95 and SAP97 govern activity-dependent regulation of
synaptic AMPA receptor function. Neuron 51, 99–111.
Schnell, E., Sizemore, M., Karimzadegan, S., Chen, L., Bredt, D.S., and Nicoll,
R.A. (2002). Direct interactions between PSD-95 and stargazin control synap-
tic AMPA receptor number. Proc. Natl. Acad. Sci. USA 99, 13902–13907.
Sheng, M., and Kim, M.J. (2002). Postsynaptic signaling and plasticity
mechanisms. Science 298, 776–780.
Shepherd, J.D., and Huganir, R.L. (2007). The cell biology of synaptic plastic-
ity: AMPA receptor trafficking. Annu. Rev. Cell Dev. Biol. 23, 613–643.
Smith, K.E., Gibson, E.S., and Dell’Acqua, M.L. (2006). cAMP-dependent
protein kinase postsynaptic localization regulated by NMDA receptor activa-262 Neuron 57, 248–262, January 24, 2008 ª2008 Elsevier Inc.tion through translocation of an A-kinase anchoring protein scaffold protein.
J. Neurosci. 26, 2391–2402.
Stein, V., House, D.R., Bredt, D.S., and Nicoll, R.A. (2003). Postsynaptic den-
sity-95 mimics and occludes hippocampal long-term potentiation and en-
hances long-term depression. J. Neurosci. 23, 5503–5506.
Tavalin, S.J., Colledge, M., Hell, J.W., Langeberg, L.K., Huganir, R.L., and
Scott, J.D. (2002). Regulation of GluR1 by the A-kinase anchoring protein 79
(AKAP79) signaling complex shares properties with long-term depression.
J. Neurosci. 22, 3044–3051.
Topinka, J.R., and Bredt, D.S. (1998). N-terminal palmitoylation of PSD-95
regulates association with cell membranes and interaction with K+ channel
Kv1.4. Neuron 20, 125–134.
Woods, D.F., Hough, C., Peel, D., Callaini, G., and Bryant, P.J. (1996). Dlg
protein is required for junction structure, cell polarity, and proliferation control
in Drosophila epithelia. J. Cell Biol. 134, 1469–1482.
